Institute of Drug R&D, NJU
南京大学 药物开发研究所
China
1 September 2018 - 31 August 2019
Principal institution: Nanjing University (NJU)
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Institute of Drug R&D, NJU published between 1 September 2018 - 31 August 2019 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
2 | 0.63 |
Outputs by subject (Share)
Subject | Count | Share | |
---|---|---|---|
Life Sciences | 1 | 0.32 | |
Chemistry | 2 | 0.63 | |
Physical Sciences | 1 | 0.31 |
Top articles by Altmetric score in current window
Perfluorocarbon regulates the intratumoural environment to enhance hypoxia-based agent efficacy
Nature Communications
2019-04-05
Perfluorocarbon nanoparticle-mediated platelet inhibition promotes intratumoral infiltration of T cells and boosts immunotherapy.
Proceedings of the National Academy of Sciences of the United States of America
2019-05-29

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.